Volume 20, Issue 3

Search all Inflammopharmacology articles

June 2012

Special Issue: Inflammation in acute and chronic neurological and psychiatric diseases

Issue Editor:

Parto S. Khansari

7 articles in this issue

Inflammation in neurological and psychiatric diseases
Parto S. Khansari
Beata Sperlagh
Inflammation in acute and chronic neurological and psychiatric diseases 24 February 2012 Pages: 103 - 107
The role of inflammatory processes in Alzheimer’s disease
G. Joseph Broussard
Jennifer Mytar
Gloria J. Klapstein
Inflammation in acute and chronic neurological and psychiatric diseases 26 April 2012 Pages: 109 - 126
New drug targets in depression: inflammatory, cell-mediated immune, oxidative and nitrosative stress, mitochondrial, antioxidant, and neuroprogressive pathways. And new drug candidates—Nrf2 activators and GSK-3 inhibitors
Michael Maes
Zdenĕk Fišar
Michael Berk
Inflammation in Acute and Chronic Neurological and Psychiatric Diseases 24 January 2012 Pages: 127 - 150
Chemical genetics of neuroinflammation: natural and synthetic compounds as microglial inhibitors
Kyoungho Suk
Jiyeon Ock
Inflammation in acute and chronic neurological and psychiatric diseases 22 December 2011 Pages: 151 - 158
NSAIDs in the treatment and/or prevention of neurological disorders
Parto S. Khansari
Leanne Coyne
Inflammation in acute and chronic neurological and psychiatric diseases 10 January 2012 Pages: 159 - 167
Effects of antidepressants and cyclooxygenase-2 inhibitor on cytokines and kynurenines in stimulated in vitro blood culture from depressed patients
Daniela L. Krause
Michael Riedel
Aye-Mu Myint
Inflammation in acute and chronic neurological and psychiatric diseases 12 January 2012 Pages: 169 - 176
Anti-inflammatory properties and pharmacological induction of Hsp70 after brain injury
Nuri Kim
Jong Youl Kim
Midori A. Yenari
Inflammation in acute and chronic neurological and psychiatric diseases 13 January 2012 Pages: 177 - 185

Volume 20, Issue 3

Inflammation in neurological and psychiatric diseases

The role of inflammatory processes in Alzheimer’s disease

New drug targets in depression: inflammatory, cell-mediated immune, oxidative and nitrosative stress, mitochondrial, antioxidant, and neuroprogressive pathways. And new drug candidates—Nrf2 activators and GSK-3 inhibitors

Chemical genetics of neuroinflammation: natural and synthetic compounds as microglial inhibitors

NSAIDs in the treatment and/or prevention of neurological disorders

Effects of antidepressants and cyclooxygenase-2 inhibitor on cytokines and kynurenines in stimulated in vitro blood culture from depressed patients

Anti-inflammatory properties and pharmacological induction of Hsp70 after brain injury

Search

Navigation